|
Getting your Trinity Audio player ready...
|
Every patient interaction, prescription, and transaction will now be digitally recorded and monitored—greatly minimizing the risk of manipulation, theft, and the circulation of counterfeit medicines.
Health Cabinet Secretary Aden Duale made this announcement during the 45th Annual Scientific Conference of the Pharmaceutical Society of Kenya (PSK) in Mombasa. He called for public support as the Ministry advances the digital transformation of healthcare, including the integration of community pharmacies into the national digital superhighway.
He reaffirmed the government’s commitment to boosting local pharmaceutical manufacturing under the Buy Kenya, Build Kenya initiative, anchored in a Presidential Directive, and stressed the vital role of innovation and regulation in improving health outcomes.
Duale asked PSK to help identify policy barriers and advocate for reforms to unlock the sector’s full potential. He emphasized PSK’s role in shaping the pharmacy benefit package under Universal Health Coverage (UHC), supporting the Pharmacy and Poisons Board (PPB) in achieving WHO Maturity Level 3, and aligning regulatory frameworks with international standards.
The CS outlined five policy priorities for the next phase of pharmaceutical regulation, with digitalization topping the list to enhance traceability and eliminate substandard medical products.
He also underscored the importance of integrating pharmacy services into UHC benefits and urged PSK to champion access and quality assurance.
PSK President Dr. Louis Machogu reiterated the Society’s commitment to promoting best practices in pharmacy, advancing pharmaceutical care, and supporting the Quality Healthcare and Patient Safety Bill.
Duale concluded by highlighting the reform agenda as a pivotal opportunity to strengthen public trust and foster meaningful partnerships across the health sector.
